$4.75
3.71% yesterday
Nasdaq, Aug 12, 10:03 pm CET
ISIN
US92859E1082
Symbol
VVOS

Vivos Therapeutics Inc Stock price

$4.75
-2.20 31.65% 1M
+0.87 22.42% 6M
+0.46 10.72% YTD
+2.63 124.06% 1Y
-28.50 85.71% 3Y
-220.00 97.89% 5Y
-220.00 97.89% 10Y
-220.00 97.89% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.17 3.71%

Key metrics

Basic
Market capitalization
$26.6m
Enterprise Value
$24.3m
Net debt
positive
Cash
$2.3m
Shares outstanding
5.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.8 | 1.7
EV/Sales
1.7 | 1.6
EV/FCF
negative
P/B
6.0
Financial Health
Equity Ratio
52.0%
Return on Equity
-140.0%
ROCE
-171.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$14.6m | $15.6m
EBITDA
$-10.7m | $-9.3m
EBIT
$-11.3m | $-11.7m
Net Income
$-11.2m | $-9.3m
Free Cash Flow
$-14.5m
Growth (TTM | estimate)
Revenue
9.4% | 3.8%
EBITDA
30.9% | 12.4%
EBIT
29.7% | -4.4%
Net Income
28.1% | 17.0%
Free Cash Flow
-24.7%
Margin (TTM | estimate)
Gross
58.7%
EBITDA
-73.1% | -59.5%
EBIT
-77.3%
Net
-76.8% | -59.3%
Free Cash Flow
-99.2%
More
EPS
$-1.3
FCF per Share
$-2.5
Short interest
5.9%
Employees
119
Rev per Employee
$130.0k
Show more

Is Vivos Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Vivos Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Vivos Therapeutics Inc forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Vivos Therapeutics Inc forecast:

Buy
75%
Hold
25%

Financial data from Vivos Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
15 15
9% 9%
100%
- Direct Costs 6.04 6.04
10% 10%
41%
8.59 8.59
9% 9%
59%
- Selling and Administrative Expenses 19 19
17% 17%
132%
- Research and Development Expense - -
-
-
-11 -11
31% 31%
-73%
- Depreciation and Amortization 0.61 0.61
2% 2%
4%
EBIT (Operating Income) EBIT -11 -11
30% 30%
-77%
Net Profit -11 -11
28% 28%
-77%

In millions USD.

Don't miss a Thing! We will send you all news about Vivos Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vivos Therapeutics Inc Stock News

Neutral
GlobeNewsWire
about 2 months ago
LITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leader in proprietary, non-invasive treatments for obstructive sleep apnea (OSA), today announced that the European Journal of Pediatrics has published the results of a groundbreaking multicenter clinical trial evidencing positive results for the treatment of OSA in children...
Neutral
Seeking Alpha
3 months ago
Vivos Therapeutics, Inc. (NASDAQ:VVOS ) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Brad Amman - CFO Kirk Huntsman - Chairman and CEO Conference Call Participants Do Kim - Water Tower Research Lucas Ward - Ascendiant Capital Markets Operator Good day, everyone. And welcome to the Vivos Therapeutics First Quarter 2025 Earnings Call.
Neutral
GlobeNewsWire
3 months ago
LITTLETON, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) and snoring in adults and moderate t...
More Vivos Therapeutics Inc News

Company Profile

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Highlands Ranch, CO.

Head office United States
CEO R. Huntsman
Employees 119
Founded 2016
Website vivos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today